作　　者： (雷霆）;

机构地区： 陕西省康复医院,陕西西安710065

出　　处： 《临床医学研究与实践》 2017年第25期53-54,共2页

摘　　要： 目的探究盐酸右美托咪定复合舒芬太尼对脑瘫手术患儿生命体征及疼痛的影响。方法将我院接诊的脑瘫手术患儿112例随机分为对照组和观察组,各56例。对照组予以舒芬太尼治疗,观察组予以盐酸右美托咪定复合舒芬太尼治疗。术后比较两组患儿的生命体征、疼痛评分及不良反应发生情况。结果两组患儿的SBP、HR、SPO_2、DBP以及在术毕、术后1、12h的疼痛评分比较,差异不显著(P>0.05);观察组不良反应发生率低于对照组(P<0.05)。结论盐酸右美托咪定复合舒芬太尼用于小儿脑瘫手术的应用价值较高,镇痛效果较好,不良反应较少。 Objective To investigate the effect of dexmedetomidine hydrochloride combined with sufentanil on vital signs and pain in children with cerebral palsy surgery. Methods One hundred and twelve children with cerebral palsy surgery in our hospital were randomly divided into control group and observation group, with 56 cases in each group. The control group was given sufentanil, while the observation group was given dexmedetomidine hydrochloride combined with sufen- tanil. After surgery, the vital signs, pain scores and adverse reactions of the two groups were compared. Results There were no significant differences in SBP, HR, SPO2, DBP and pain scores at 1, 12 hours after surgery between the two groups （P〉 0.05）. The incidence rate of adverse reactions in the observation group was lower than that in the control group （P〈0.05）. Conclusion Dexmedetomidine hydrochloride combined with sufentanil in children with cerebral palsy surgery has higher application value, better analgesic effect and less adverse reactions.

关 键 词： 盐酸右美托咪定 舒芬太尼 脑瘫手术 生命体征 疼痛